Comparative Cost-Effectiveness of Plerixafor Plus Granulocyte-Colony Stimulating Factor Versus Cyclophosphamide Plus Granulocyte-Colony Stimulating Factor for Autologous Peripheral Blood Stem Cell Mobilization in Patients With Multiple Myeloma